GIM
IMVT icon

Granahan Investment Management’s Immunovant IMVT Stock Holding History

Granahan Investment Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Sell
206,372
-38,058
-16% -$1.16M 0.28% 83
2026
Q1 		$6.07M Buy
244,430
+14,242
+6% +$369K 0.29% 90
2025
Q4 		$5.85M Sell
230,188
-36,033
-14% -$803K 0.25% 94
2025
Q3 		$4.29M Buy
266,221
+53,133
+25% +$860K 0.18% 107
2025
Q2 		$3.41M Buy
213,088
+40,772
+24% +$617K 0.14% 118
2025
Q1 		$2.94M Buy
172,316
+22,920
+15% +$479K 0.15% 121
2024
Q4 		$3.7M Buy
+149,396
New +$4.24M 0.15% 126

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Granahan Investment Management's IMVT Position: Q2 2026 in Review

Granahan Investment Management reduced its Immunovant (IMVT) stake by 16% in Q2 2026, selling an estimated $1.16M and leaving 206,372 shares worth $7.95M. The position accounts for 0.28% of the portfolio, ranked #83.

Granahan Investment Management first reported a position in IMVT in Q4 2024 and has held it in 7 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Granahan Investment Management held 206,372 shares of Immunovant worth $7.95M as of Q2 2026.
  • Granahan Investment Management sold 38,058 Immunovant shares in Q2 2026, an estimated $1.16M.
  • Immunovant made up 0.28% of Granahan Investment Management's portfolio in Q2 2026, its #83 holding.
  • Granahan Investment Management first reported a position in Immunovant in Q4 2024 and has held it in 7 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.